Alliancebernstein L.P. Bio Xcel Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

A detailed history of Alliancebernstein L.P. transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 29,990 shares of BTAI stock, worth $38,387. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,990

Previous 29,990 -0.0%

Holding current value

$38,387

Previous $88,000 4.55%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$2.32 - $5.51 $13,664 - $32,453	-5,890 Reduced 16.42%	29,990 $88,000
Q2 2023 Aug 15, 2023	BUY	$6.39 - $28.58 $75,913 - $339,530	11,880 Added 49.5%	35,880 $238,000
Q4 2022 Feb 14, 2023	BUY	$10.25 - $22.43 $23,575 - $51,589	2,300 Added 10.6%	24,000 $515,000
Q2 2022 Aug 15, 2022	SELL	$9.03 - $21.55 $177,602 - $423,845	-19,668 Reduced 47.54%	21,700 $286,000
Q1 2022 May 13, 2022	SELL	$15.0 - $22.83 $22 Million - $33.5 Million	-1,467,400 Reduced 97.26%	41,368 $865,000

Q4 2021 Feb 14, 2022	BUY	$20.12 - $35.09 $9.83 Million - $17.1 Million	488,513 Added 47.88%	1,508,768 $30.7 Million
Q3 2021 Nov 10, 2021	BUY	$23.84 - $32.03 $1.84 Million - $2.47 Million	76,995 Added 8.16%	1,020,255 $31 Million
Q2 2021 Jul 30, 2021	BUY	$29.06 - $38.83 $3.7 Million - $4.95 Million	127,379 Added 15.61%	943,260 $27.4 Million
Q1 2021 May 06, 2021	BUY	$39.04 - $64.6 $5.09 Million - $8.43 Million	130,470 Added 19.04%	815,881 $35.2 Million
Q4 2020 Feb 08, 2021	BUY	$42.46 - $56.58 $4.04 Million - $5.38 Million	95,126 Added 16.12%	685,411 $31.7 Million
Q3 2020 Nov 12, 2020	BUY	$37.44 - $64.63 $3.22 Million - $5.55 Million	85,880 Added 17.03%	590,285 $25.6 Million
Q2 2020 Aug 13, 2020	BUY	$17.62 - $58.71 $8.67 Million - $28.9 Million	492,105 Added 4000.85%	504,405 $26.7 Million
Q1 2020 May 14, 2020	BUY	$12.26 - $41.14 $150,798 - $506,022	12,300 New	12,300 $275,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

6.6M

Call Options Held

85K

Put Options Held

221K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $35.9M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Bio Xcel Therapeutics, Inc. Transaction History